More than a dozen classes of prescription medications have been linked to phantosmia, the perception of smells that aren’t actually there. The most well-documented include cholesterol-lowering drugs, antidepressants, painkillers, diabetes medications, proton pump inhibitors (acid reflux drugs), anticonvulsants, calcium channel blockers, sedatives, and muscle relaxants. If you’ve recently started or stopped a medication and begun smelling something that no one else can detect, the two events may be connected.
Drug Classes Most Strongly Linked to Phantom Smells
A large study of U.S. adults published through the National Institutes of Health identified nine prescription drug classes whose users reported phantom odors at significantly higher rates than non-users. Those classes are: cholesterol-lowering agents (statins and similar drugs), antidepressants, analgesics (pain medications), antidiabetic agents, proton pump inhibitors, anticonvulsants, calcium channel blockers, the combined group of anti-anxiety medications, sedatives, and hypnotics, and muscle relaxants.
The association was especially strong in adults over 60. In that age group, diabetes medications, cholesterol-lowering drugs, and proton pump inhibitors were each associated with 74 to 88 percent greater odds of experiencing phantom odors compared to people not taking those drugs. That doesn’t mean these medications will definitely cause phantosmia, but the statistical link is notable and consistent.
Antibiotics and Chemotherapy Drugs
Several antibiotics are specifically tied to smell and taste disruptions. An analysis of FDA adverse event reports flagged azithromycin, clarithromycin, doxycycline, levofloxacin, and moxifloxacin as having significant associations with olfactory and taste disorders, including olfactory hallucinations. Macrolide antibiotics (like azithromycin and clarithromycin) and fluoroquinolones (like levofloxacin and moxifloxacin) appear most frequently in these reports.
Chemotherapy agents are among the best-documented causes. The drugs most frequently linked to taste and smell disturbances include docetaxel, paclitaxel, nab-paclitaxel, capecitabine, cyclophosphamide, epirubicin, anthracyclines, and oral 5-FU analogues. Sensory changes typically develop two to three weeks after starting treatment and persist throughout therapy. Symptoms tend to peak within five to seven days after each infusion, then gradually ease before the next cycle.
Antidepressants: Both Starting and Stopping
Antidepressants appear on the list of drugs associated with phantom smells, but the relationship works in both directions. Taking an antidepressant can alter your sense of smell, and abruptly stopping one can trigger phantosmia as part of discontinuation syndrome. One documented case involved a patient who developed olfactory hallucinations two weeks after suddenly stopping paroxetine (Paxil). When the medication was restarted, the phantom smells disappeared within days.
This pattern fits the broader profile of SSRI discontinuation syndrome, which typically begins within the first two weeks after abruptly stopping an SSRI. If you’re experiencing phantom smells after recently stopping an antidepressant, that timing is a meaningful clue. Tapering off these medications gradually, rather than stopping cold, reduces the risk of sensory side effects.
Sedatives and Benzodiazepines
Anti-anxiety medications and sedatives, particularly benzodiazepines, have their own connection to phantosmia. In one reported case, a patient developed olfactory hallucinations after discontinuing clonazepam (Klonopin). When the medication was restarted, all symptoms resolved overnight, including the phantom smells. Like antidepressants, benzodiazepines can cause sensory disturbances during withdrawal, making abrupt discontinuation risky.
Blood Pressure and Heart Medications
Two categories of cardiovascular drugs show up in phantosmia research. Calcium channel blockers, used to treat high blood pressure and certain heart conditions, were among the nine drug classes with elevated rates of phantom odor perception. ACE inhibitors like captopril and enalapril work through a different mechanism: they can deplete zinc, a mineral critical to normal smell and taste function. Diuretics, commonly prescribed alongside blood pressure drugs, also contribute to zinc depletion.
How Medications Disrupt Your Sense of Smell
Medications can trigger phantom smells through several pathways. Some directly affect the olfactory nerve or the brain regions that process smell. Others cause dry mouth, which might seem unrelated but actually alters the chemical environment in your nasal and oral passages. Drug classes known to cause significant dry mouth include diuretics, antidepressants, antihistamines, respiratory agents, and anticholinergics.
Zinc depletion is another well-established mechanism. Zinc plays a central role in how your olfactory system functions, and when medications drain your body’s zinc stores, smell distortions can follow. The drugs most clearly tied to this pathway are ACE inhibitors (captopril and enalapril) and diuretics. Zinc supplementation may help reduce the risk of these drug-induced smell disturbances, particularly in people already at risk due to age or diet.
What Recovery Looks Like
The good news is that medication-induced phantosmia is generally reversible. In most documented cases, phantom smells resolve after the offending drug is discontinued or the dose is adjusted. The timeline varies. For antidepressant or benzodiazepine withdrawal, symptoms can resolve within days once the medication is reintroduced or properly tapered. Chemotherapy-related smell changes tend to persist throughout treatment but typically improve after therapy ends.
If you suspect a medication is causing phantom smells, the most useful step is tracking when the symptom started relative to any changes in your prescriptions. That timeline helps narrow down which drug is responsible, especially if you take multiple medications. Zinc status is also worth investigating, particularly if you’re taking ACE inhibitors or diuretics, since correcting a deficiency can sometimes resolve the problem without switching drugs.